Connect with us

Heartland

CBD News Roundup: FDA Provides Framework for Future CBD Research

Here’s the latest CBD news: The FDA published a report detailing their plans for data collection and research improvements in the area of CBD research and regulation.  Yale researchers have funded a randomized trial that will measure the effects of CBD on the female brain with a focus on anxiety. A recent survey by University… View Article

The post CBD News Roundup: FDA Provides Framework for Future CBD Research appeared first on The CBD Insider.

Republished by Plato

Published

on

fda to collect better data about cbd

Here’s the latest CBD news:

  • The FDA published a report detailing their plans for data collection and research improvements in the area of CBD research and regulation. 
  • Yale researchers have funded a randomized trial that will measure the effects of CBD on the female brain with a focus on anxiety.
  • A recent survey by University of Michigan researchers explores CBD usage prevalence and habits among fibromyalgia sufferers. 

Table of Contents

  1. FDA Provides Framework for Future CBD Research
  2. Yale Research Group to Explore CBD’s Effects on the Female Brain
  3. Survey Shows CBD’s Popularity Among Fibromyalgia Patients

FDA Provides Framework for Future CBD Research

On January 8, a week before the Senate’s passage of the Cannabidiol and Marijuana Research Expansion Act, the Food and Drug Administration published an overview on their site detailing the current state of their CBD knowledge base as well as a “framework for building a more robust evidentiary foundation” for safer and smarter public use purposes.

The FDA addressed the following items in the report as they relate to their role in the advancement of CBD research and regulation:

  • The 2018 Farm Bill
  • CBD drug approval (epidiolex)
  • Public input on CBD issues from stakeholders
  • FDA-sponsored product sampling and research initiatives
  • Challenges in data collection
  • Unanswered questions

Of particular importance for the continued advancement of CBD research and regulation were the FDAs calls for refinement in “data approaches,” which emphasized an opt-in registry for CBD users, market-research insights, and other data-rich sources that will help assess CBD safety and efficacy more comprehensively.

With the help of the Cannabidiol and Marijuana Research Expansion Act, which is designed to support and streamline the CBD data-collection infrastructure, the FDA seeks to define the CBD “safety profile” more completely for consumer education and regulation purposes.

Yale Research Group to Explore CBD’s Effects on the Female Brain

A team of psychology experts from Women’s Health Research at Yale (WHRY) led by Assistant Professor of Psychiatry Dr. Sarah Lichenstein announced on January 11th that their department has funded a randomized, double-blind, placebo-controlled study to examine the effects of CBD on the female brain.

Aiming to expand on the sparse number of findings related to gender-specific effects of CBD, the study will use functional MRI technology to assess activity levels in stress centers of the brain after CBD is administered to participants.

The Yale announcement cites known discrepancies in anxiety prevalence across genders—women are affected twice as often as men—and safety concerns related to benzodiazepine use as key motivators driving this vein of CBD research.

According to WHRY Director Carol M. Mazure, Ph.D., “Dr. Liechtenstein’s study will help us to understand the mechanisms underlying CBD and whether it has therapeutic potential for anxiety.”

Much of the gender-specific research that has been conducted on CBD was summarized in a 4-panel meeting held by the FDA in November of last year, which provided similar insights into the greater prevalence of anxiety and anxiety medication use in women. 

Survey Shows CBD’s Popularity Among Fibromyalgia Patients

The results of a survey published in the Journal of Pain on January 2 by University of Michigan Medical School experts found that almost two-thirds of surveyed fibromyalgia patients are using or have used CBD products.

Survey data revealed that 29.4% of the 2,701 respondents used CBD in the past, and 32.4% were using it at the time, totaling 61.8%.

Researchers also assessed several important dimensions related to the perception and use of CBD by fibromyalgia patients, including: 

  • Reasons for use and discontinuation
  • Communication with healthcare professionals about CBD
  • Perceptions of CBD effectiveness and safety

Most of the respondents used CBD to address “inadequate symptom relief,” and two-thirds of CBD users disclosed their use to their physicians. 

Finally, respondents reported mild to moderate improvements across multiple symptoms. 

Authors called for more studies to further devine CBD’s treatment potential and safety for this population and other chronic pain sufferers. 

The CBD Insider Editorial Team

The mission of The CBD Insider is to provide consumers with a way to find high-quality, safe, and well-formulated CBD products. Our editorial team of passionate industry professionals achieves this mission by providing unbiased, trustworthy, and well-researched reporting about the CBD industry.

Source: https://thecbdinsider.com/news/cbd-news-roundup-fda-provides-framework-for-future-cbd-research/

Heartland

Charlotte’s Web’s CW Labs Announce New Scientific Collaboration Researching Hemp CBD Efficacy

Harvard Medical School’s Dr. Staci Gruber, Ph.D. is lead investigator BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ – (TSX: CWEB) (OTCQX: CWBHF) Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, and the Company. […]

Republished by Plato

Published

on

Harvard Medical School’s Dr. Staci Gruber, Ph.D. is lead investigator

BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ – (TSX: CWEB) (OTCQX: CWBHF) Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, and the Company. Funding and product support are provided by the CW Labs division of Charlotte’s Web Inc.

Two distinct clinical trials will be overseen by lead researcher/investigator Dr. Staci A. Gruber, Ph. D, Associate Professor of Psychiatry at Harvard Medical School and Director of the MIND program at McLean Hospital in Belmont, Mass. These two studies will investigate the efficacy of a custom-formulated, hemp-derived high-CBD product. Clinical trial results are to be published in 2022. Dr. Gruber is also conducting a number of other studies, including a longitudinal observational study of Veterans who use a Charlotte’s Web product.

Dr. Gruber’s Marijuana Investigations for Neuroscientific Discovery (MIND) Program, established in 2014, is the first of its kind, and is dedicated to studying the long-term impact of cannabis and cannabinoids for medical and adult use which utilizes various clinical and cognitive tools as well as multimodal neuroimaging techniques.

We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials. Charlotte’s Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country’s top scientists.

Tim Orr, President of Charlotte’s Web’s CW Labs divison

For More Information About the MIND Program: https://www.drstacigruber.com/

About the MIND Program:

In 2014 Dr. Staci Gruber launched the Marijuana Investigations for Neuroscientific Discovery (MIND) program at Mclean Hospital, a Harvard Medical School affiliate. The MIND program is the first program of its kind designed to clarify the specific effects of medical cannabis use and is designed to support a wide range of study designs that generate ecologically valid, empirically sound data to close the gap between policy and science. MIND utilizes valid, robust research models and supports numerous projects designed to address the impact of medical cannabis on important variables such as cognition, brain structure and function, mood, conventional medication use, quality of life, pain, sleep, and other health-related measures. Through observational longitudinal investigations, survey studies, and clinical trials of custom-formulated cannabinoid products, MIND aims to examine the unique and synergistic effects of cannabis and its constituents to determine the efficacy of cannabinoids for specific conditions and diseases and to clarify the overall impact of cannabinoid-based treatments on physical and mental health. MIND is poised to improve patients’ overall wellbeing by striving to harness the therapeutic potential while minimizing harms of cannabinoid-based treatment.

About Charlotte’s Web and its CW Labs Division

Charlotte’s Web Labs (“CW Labs”) is the research and development division of Charlotte’s Web, advancing science around hemp-derived phytocannabinoids, terpenes and flavonoid compounds. CW Labs is headquartered at the Hauptmann Woodward Research Institute on the campus of the University at Buffalo’s Jacobs School of Medicine and The Center for Integrated Global Biomedical Sciences, and is part of the State University of New York (SUNY) network of 64 national and international research and medical institutions.

About Charlotte’s Web Holdings, Inc.

Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Boulder, Colorado, is the market leader in the production and distribution of innovative hemp-derived cannabidiol (“CBD”) wellness products under a family of brands which includes Charlotte’s Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp. The Company’s premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into whole-plant hemp extracts containing a full spectrum of naturally occurring phytocannabinoids including CBD, CBC, CBG, terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, stress, inflammation recovery), CBD capsules,CBD topical creams and lotions, as well as CBD pet products for dogs. Charlotte’s Web is the number one CBD brand in the USA and distributed through more than 22,000 retail locations, select distributors and online through the Company’s website at www.CharlottesWeb.com.

Charlotte’s Web was founded by the Stanley Brothers with a mission to unleash the healing powers of botanicals through compassion and science, benefiting the planet and all who live upon it. Charlotte’s Web is a socially and environmentally conscious company and is committed to using business as a force for good and a catalyst for innovation. The Company weighs sound business decisions with consideration for how its efforts affect employees, customers, the environment, and diverse communities. The rate the Company pays for agricultural products reflects a fair and sustainable rate driving higher quality yield, encouraging regenerative farming practices, and supporting U.S. farming communities. Management believes that its socially oriented and environmentally responsible actions have a positive impact on its customers, suppliers, employees, and stakeholders. Charlotte’s Web donates a portion of its pre-tax earnings to charitable organizations.

Subscribe to Charlotte’s Web investor news.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.


Get Our Sunday Newsletter


Source: https://www.newcannabisventures.com/charlottes-webs-cw-labs-announce-new-scientific-collaboration-researching-hemp-cbd-efficacy/

Continue Reading

Heartland

Is cbd oil worth it’s price or should I stick to flower?

Republished by Plato

Published

on

Tldr- bud or bottle?

Hi

So, I have been smoking high quality outdoor/greenhouse CBD/CBG from Beleafer. Now, my problem is, I dont really feel effects anymore, like, I use my cbd flower to mix with normal high potency weed and it works great, I feel less paranoia, thats all well, but as I say, if I smoke cbd alone its really like im doing something for nothing, this could be because I only get ounces from Beleafer as they last me months, but I probably have a tolerance with each strain by the time I finish it.

My issue is this. I need relief badly(psychological and physical issues), and when I used a high quality cbd oil, it helped, at low 5% dosage, but it was a pretty penny.

When I look at the cbd I want to get now its 129€ for 40% or I can get 2x 20% for the same price. They are 10ml bottles.

HOWEVER, I can get an ounce of indoor cbd for a similar slightly less price, only issue is shipping times, AND – IS SHIPPING OF CBD FLOWER STILL POSSIBLE OR TOTALLY STOPPED? This is probably my only issue now thinking about it.

I digress, basically I can get good strong cbd to smoke for months, or I can get a bottle of oil that could last a month depending if it works and if I stick to dosages instead of just start doing drops all day.

I enjoy cbd and it does work, I just dont know if I have a high tolerance now and it means I have to only fork out on high potency stuff.

Oh, the point of this post is that with smoking cbd, I cant say I feel any health benefits like pain relief etc, however when I used oil I think it definitely helped in more ways than just one (relaxed after a bong)

What would you do in this case? Bud or bottle?

Oh im in France so this makes it difficult with certain brands that dont ship intl.

Source: https://www.reddit.com/r/CBD/comments/lt0hvr/is_cbd_oil_worth_its_price_or_should_i_stick_to/

Continue Reading

Heartland

Republished by Plato

Published

on

Source:

Continue Reading
Heartland4 days ago

Florida Bill Aims to Legalize Medical Magic Mushrooms

Heartland4 days ago

Delta 8: Shipping Vape Ban Goes Into Effect Soon – What Does It Means?

Material5 days ago

Nanocrystallization of a Ti40 cladding layer by ultrasonic impact to improve burn resistance

Metal4 days ago

Local Turkish DKP grade scrap prices remain stable

Heartland3 days ago

Explained: How CBD Oil is Different Than CBD Capsule?

Material5 days ago

Wear behavior of nanostructured carbo-austempered cast steels under rolling-sliding conditions

Heartland5 days ago

Heartland4 days ago

Bermuda Prepares To Lock Horns With United Kingdom Over Adult Use Cannabis

Material4 days ago

Chemical attack and corrosion resistance of concrete prepared with electrolyzed water

Heartland5 days ago

CBD and Inflammation

Material5 days ago

Growth kinetics of the FeB/Fe2B boride layer on the surface of 4Cr5MoSiV1 steel: experiments and modelling

Material4 days ago

Competitive mechanisms occurring during quenching and partitioning of three silicon variants of 0.4 wt.% carbon steels

Heartland5 days ago

Unnamed Company Tried to Buy Aphria While It Was Negotiating Tilray Merger

Heartland4 days ago

Where To Buy CBD in Fort Worth

Heartland5 days ago

Efficacy of CBD Edibles

Material5 days ago

Influence of heavy metal oxides to the mechanical and radiation shielding properties of borate and silica glass system

Heartland5 days ago

Questions about taking CBD oil for anxiety

Material5 days ago

Activated carbon electrode with promising specific capacitance based on potassium bromide redox additive electrolyte for supercapacitor application

Heartland4 days ago

CBD Has Been Getting Me High

Heartland5 days ago

Kanabo looks fully valued

Heartland4 days ago

Sir Keir Starmer rules out relaxing cannabis laws in the UK

Heartland5 days ago

drug test soon help

Heartland5 days ago

Hemp NZ appoints new board chair

Heartland18 hours ago

Heartland5 days ago

5 best CBD gummies you can buy in the UK in 2021

Material5 days ago

Investigation of microstructural attributes of steel surfaces through magneto-optical Kerr effect

Heartland4 days ago

Metal4 days ago

Ex-China plate prices up sharply following surge in local prices

Heartland3 days ago

Uncategorized2 days ago

What CBD Oil is Right For Me?

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America